Long-acting injectable contraception with depot medroxyprogesterone acetate

This publication has 32 references indexed in Scilit:

• Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer
  Contraception, 1992
• Breast cancer and depot-medroxyprogesterone acetate: a multinational study: WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES
  The Lancet, 1991
• Depot‐medroxyprogesterone acetate (DMPA) and risk of edometrial cancer
  International Journal of Cancer, 1991
• Depo Provera: A Profile of Current Users
  Australian and New Zealand Journal of Obstetrics and Gynaecology, 1990
• Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer
  Journal of Clinical Epidemiology, 1990
• Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.
  BMJ, 1989
• The Food and Drug Administration and Medroxyprogesterone Acetate
  Published by American Medical Association (AMA) ,1983
• Blood levels of medroxyprogesterone acetate after multiple injections of DepoProvera or CycloProvera
  Contraception, 1979
• Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPA
  Journal of Clinical Endocrinology & Metabolism, 1977
• Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)
  Contraception, 1974